NHS vs private
Compare NHS and private access without turning the decision into a price-only or speed-only choice.
Compare the kind of evidence each access type can actually show you
NHS and private access should not be compared in the same way. NHS questions are usually about eligibility, referral and local rollout. Private questions can also include provider checks, support and recently checked public details.
NHS access guide
Best when the main question is who decides, what the local pathway looks like and whether NHS weight-management support is available where you live.
- Start with
- Eligibility and pathway
- What varies most
- Local rollout and waiting
- Provider price table?
- Usually no
- Best next step
- Check eligibility guide
NHS access is not usually about comparing provider prices. The more useful questions are who qualifies, who decides, what service exists locally and how follow-up works.
Private access guide
Best when you want to compare provider type, support, last-checked dates and what the public provider information can tell you before opening one provider page in full.
- Providers to browse
- 77
- Details checked
- 752
- Medicine groups covered
- 7
- Last checked
- 29 Apr 2026
This site currently brings together 77 provider overviews and 752 checked details across injections and tablets. Current details can change, so use them as a comparison aid and confirm live information with the provider.
NHS and private weight-loss treatment are different access routes, not just different prices
Short version: NHS access is shaped by eligibility, local pathways and waiting times. Private access is easier to compare online, but you still need proper assessment, clear costs, support and regulator information.
Best next step: compare access first. Then compare providers only if private care is the route you are checking.
Best for cost protection
NHS routes, where available and suitable, avoid private medicine and service fees.
Best for comparing online
Private routes, because provider terms, costs and support can be reviewed side by side.
Best for safety
Either route can be appropriate only when assessment and follow-up are clear.
Which route fits which situation?
NHS route
Best first check if you may qualify and want structured care without private provider fees.
Private online clinic
Best for comparing access, costs, support and provider terms online.
Programme-led provider
Best when coaching, follow-up or broader support is a major part of the service.
Pharmacy-led provider
Best when you want to compare pharmacy assessment, supply and support information.
NHS route: pros and cons
- Can reduce direct private costs if available.
- May involve eligibility criteria, referral and local waiting times.
- Availability can differ by area.
Private route: pros and cons
- Easier to compare online by provider, cost and support.
- Can involve medicine, consultation, delivery or programme costs.
- Quality depends on assessment, regulation and follow-up.
Compare providers
Private service checks
Use the provider directory to compare service type, treatment areas and review dates.
Understand eligibility
Questions before treatment
Use the eligibility page to understand the kinds of checks that may apply.
Compare full costs
Beyond headline price
Use the costs page to compare consultation, delivery, follow-up and programme fees.
Source notes
These notes explain the basis for the page in plain English: what was checked, when it was checked and where the information came from.
Cqc Online Primary Care Context
CQC online-primary-care guidance was reviewed for private online-service oversight context.
Source: CQC: Online primary care services
Used to support cautious wording about online-service regulation and private-provider legitimacy checks.
Nice Tirzepatide Access Context
NICE tirzepatide guidance was reviewed for UK access context.
Source: NICE TA1026: tirzepatide for managing overweight and obesity
Reviewed to explain staged UK access context around current weekly injection routes.
Nice Semaglutide Access Context
NICE semaglutide guidance was reviewed for UK access context.
Source: NICE TA875: semaglutide for managing overweight and obesity
Reviewed to explain that national guidance and real-world access are related but not identical.
Nhs Obesity Treatment Context
NHS guidance was reviewed for broad obesity treatment pathway context.
Source: NHS: Treatment for obesity
Reviewed for cautious explanation of NHS pathways, treatment context and local-service differences.
Important information
This website is an informational comparison hub. It does not prescribe, supply or sell prescription-only medicines. Suitability depends on a regulated clinical assessment.
Some links may be affiliate or commercial links. Commercial relationships must not change the way safety, eligibility, checked details or editorial context are presented.